Drug
Cefotaxime clinical trials
- studies test it
- 12
- open now
- 2
- in phase 3
- 3
- first study started
- 1998
Keep track of what changes. Save the Cefotaxime studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2015 (3)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 3
- 3
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 11
Centre Hospitalier Universitaire de Besancon (2) · Tanta University (2) · Anabio R&D (1) · Assistance Publique - Hôpitaux de Paris (1) · University Medical Center Groningen (1) · Poitiers University Hospital (1) · Dr Ahmed Ali Elbaz (1) · University of California, San Francisco (1)
Often tested with
Tested in the same studies.
Ceftriaxone (3) · Ciprofloxacin (2) · Bacillus subtilis (1) · Bacillus clausii (1) · Acetylcysteine (1) · Metronidazole (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Netilmicin (1)
Studies
Open first, then newest update. How each study uses Cefotaxime is read from its arms, and is right about nine times in ten.
Testing it · 12
- Aminoglycosides in Early SepsisRecruitingPhase 4University Hospital, AkershusNCT06712641Written as Cefotaxime
- Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial PeritonitisRecruitingPhase 3Tanta UniversityNCT04168099Written as Cefotaxime
- LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis MediaCompletedNot applicableAnabio R&DNCT05804123Written as Cefotaxime
- Meropenem vs Cefotaxime as Empirical Treatment of SBPStatus unknownPhase 4Assiut UniversityNCT05427747Written as cefotaxime
- Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)Status unknownPhase 4Centre Hospitalier Universitaire de BesanconNCT03922919Written as Cefotaxime Injection
- Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.CompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02659033Written as Cefotaxime
- Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?Status unknownPhase 3Tanta UniversityNCT02443285Written as Cefotaxime
- Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.CompletedPhase 4University Medical Center GroningenNCT02560207Written as Cefotaxime
- Cerebral Antibiotics Distribution After Acute Brain InjuryCompletedPhase 1Poitiers University HospitalNCT01059890Written as cefotaxime
- Cefotaxime Resistance in Treatment of Spontaneous Bacterial PeritonitisCompletedNot applicableDr Ahmed Ali ElbazNCT02388035Written as Cefotaxime
- Effect of, OAT3, on the Renal Secretion of CefotaximeCompletedPhase 1University of California, San FranciscoNCT00187655Written as Cefotaxime
- Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic TreatmentCompletedPhase 4Centre Hospitalier Universitaire de BesanconNCT01559753Written as Augmentin, Ceftriaxone, Cefotaxime, netilmycin, tobramycin
As the comparator · 3 — what is tested is compared with Cefotaxime
- Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LCCompletedPhase 4Korea UniversityNCT01265173Written as Cefotaxime
- Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract InfectionsCompletedPhase 4Håkan HanbergerNCT02959957Written as Cefotaxime
- Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in CirrhosisStatus unknownPhase 4University of Roma La SapienzaNCT01820026Written as Cefotaxime
Codes
What other systems call Cefotaxime · ClinicalTrials.gg INT007169
- MeSH (NLM) D002439CefotaximeConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) N2GI8B1GK7CEFOTAXIMEConfirmed FDA, NLM, Wikidata
- RxNorm 2186Confirmed FDA, Wikidata
- Wikidata Q417968cefotaximeConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C354CefotaximeOne source FDA
- DrugBank DB00493One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002439 | Cefotaxime | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | N2GI8B1GK7 | CEFOTAXIME | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2186 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417968 | cefotaxime | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C354 | Cefotaxime | One source FDA |
| DrugBank | DB00493 | — | One source Wikidata |
Also registered as cefotaxime sodium (UNII 258J72S7TZ · RxNorm 203117).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.